128 related articles for article (PubMed ID: 14985291)
1. Kinetics of visual field loss in Usher syndrome Type II.
Iannaccone A; Kritchevsky SB; Ciccarelli ML; Tedesco SA; Macaluso C; Kimberling WJ; Somes GW
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):784-92. PubMed ID: 14985291
[TBL] [Abstract][Full Text] [Related]
2. Visual acuity and visual field impairment in Usher syndrome.
Edwards A; Fishman GA; Anderson RJ; Grover S; Derlacki DJ
Arch Ophthalmol; 1998 Feb; 116(2):165-8. PubMed ID: 9488267
[TBL] [Abstract][Full Text] [Related]
3. Rate of visual field loss in retinitis pigmentosa.
Grover S; Fishman GA; Anderson RJ; Alexander KR; Derlacki DJ
Ophthalmology; 1997 Mar; 104(3):460-5. PubMed ID: 9082273
[TBL] [Abstract][Full Text] [Related]
4. Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa.
Bittner AK; Iftikhar MH; Dagnelie G
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8042-6. PubMed ID: 21896857
[TBL] [Abstract][Full Text] [Related]
5. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
[TBL] [Abstract][Full Text] [Related]
6. Natural course of visual field loss in patients with Type 2 Usher syndrome.
Fishman GA; Bozbeyoglu S; Massof RW; Kimberling W
Retina; 2007 Jun; 27(5):601-8. PubMed ID: 17558323
[TBL] [Abstract][Full Text] [Related]
7. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
8. Visual field loss in primary congenital glaucoma.
Sinha G; Patil B; Sihota R; Gupta V; Nayak B; Sharma R; Sharma A; Gupta N
J AAPOS; 2015 Apr; 19(2):124-9. PubMed ID: 25892039
[TBL] [Abstract][Full Text] [Related]
9. Variability and Errors of Manually Digitized Goldmann Visual Fields.
Barry MP; Bittner AK; Yang L; Marcus R; Iftikhar MH; Dagnelie G
Optom Vis Sci; 2016 Jul; 93(7):720-30. PubMed ID: 27058594
[TBL] [Abstract][Full Text] [Related]
10. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa.
Bittner AK; Seger K
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):299-306. PubMed ID: 29222719
[TBL] [Abstract][Full Text] [Related]
11. Patterns of visual field progression in patients with retinitis pigmentosa.
Grover S; Fishman GA; Brown J
Ophthalmology; 1998 Jun; 105(6):1069-75. PubMed ID: 9627658
[TBL] [Abstract][Full Text] [Related]
12. Longterm visual prognosis in Usher syndrome types 1 and 2.
Sadeghi AM; Eriksson K; Kimberling WJ; Sjöström A; Möller C
Acta Ophthalmol Scand; 2006 Aug; 84(4):537-44. PubMed ID: 16879578
[TBL] [Abstract][Full Text] [Related]
13. Reduced Central Retinal Artery Blood Flow Is Related to Impaired Central Visual Function in Retinitis Pigmentosa Patients.
Kayser S; Vargas P; Mendelsohn D; Han J; Bi H; Benavente A; Bittner AK
Curr Eye Res; 2017 Nov; 42(11):1503-1510. PubMed ID: 28910168
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the Visual Field Loss in Retinitis Pigmentosa Using Semi-Automated Kinetic Perimetry.
Nowomiejska K; Brzozowska A; Koss MJ; Weleber RG; Schiefer U; Rejdak K; Juenemann AG; Maciejewski R; Rejdak R
Curr Eye Res; 2016 Jul; 41(7):993-8. PubMed ID: 26470834
[TBL] [Abstract][Full Text] [Related]
15. Visual Field Progression in Retinitis Pigmentosa.
Xu M; Zhai Y; MacDonald IM
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):56. PubMed ID: 32589198
[TBL] [Abstract][Full Text] [Related]
16. Reliability of kinetic visual field testing in children with mutation-proven retinal dystrophies: Implications for therapeutic clinical trials.
Dedania VS; Liu JY; Schlegel D; Andrews CA; Branham K; Khan NW; Musch DC; Heckenlively JR; Jayasundera KT
Ophthalmic Genet; 2018; 39(1):22-28. PubMed ID: 28704108
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of visual impairment in Usher syndrome 1b and Usher syndrome 2a.
Pennings RJ; Huygen PL; Orten DJ; Wagenaar M; van Aarem A; Kremer H; Kimberling WJ; Cremers CW; Deutman AF
Acta Ophthalmol Scand; 2004 Apr; 82(2):131-9. PubMed ID: 15043528
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of visual, auditory, and olfactory function in Usher syndrome.
Seeliger M; Pfister M; Gendo K; Paasch S; Apfelstedt-Sylla E; Plinkert P; Zenner HP; Zrenner E
Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):301-7. PubMed ID: 10208263
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa.
Iannaccone A; Rispoli E; Vingolo EM; Onori P; Steindl K; Rispoli D; Pannarale MR
Doc Ophthalmol; 1995; 90(2):129-42. PubMed ID: 7497885
[TBL] [Abstract][Full Text] [Related]
20. Usher syndrome: an otoneurologic study.
Möller CG; Kimberling WJ; Davenport SL; Priluck I; White V; Biscone-Halterman K; Odkvist LM; Brookhouser PE; Lund G; Grissom TJ
Laryngoscope; 1989 Jan; 99(1):73-9. PubMed ID: 2909824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
